Ann: A1M: Supplementary Bidder's Statement, page-13

I'm going to spend some time summarising the effects of the combination - I'll post when I'm out of shock.

No need to feel sorry for the ADN arbitragers. The In Specie were a free issue, and with a cost base of $0.40c if we don't get Roll Over Relief the profit of approx 40c value - 40c cost remains 0 declarable profit. I'd feel sorrier for those who couldn't wait to sell DRM inspecie to buy more ADN. Truth be told I bought more ADN and more DRM, so what do I know.

I need time to digest this food, this feels like a meal replacement shake. Its good for you, but no substitute for a balanced fulfilling meal